Logo

Vascular Biogenics LTD

EIC Accelerator Winner From 2021

The OVAL study for VB-111 treatment of platinum-resistant ovarian cancer

Visit Website
Israel

Articles

EIC Accelerator Funding: Vascular Biogenics Ltd.'s Growth and Merger with Notable Labs

IsraelEIC Accelerator2021
Read Article
Back to All Companies

EIC Accelerator Deadline

00
Days
00
Hours
00
Minutes
00
Seconds

How Can We Help You Succeed?

AI Writer

Budget-friendly AI tools, templates and instructions

Advisory Service

Personalized support for teams with in-house writers

Full Writing

Full Writing of all Proposal Sections by Stephan Segler, PhD